Grantham, Mayo, Van Otterloo & Co (GMO)’s Essent Group ESNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-566,121
Closed -$30.8M 639
2024
Q4
$30.8M Buy
566,121
+15,137
+3% +$879K 0.1% 136
2024
Q3
$35.4M Sell
550,984
-143,991
-21% -$8.81M 0.11% 128
2024
Q2
$39.1M Buy
694,975
+38,062
+6% +$2.12M 0.13% 105
2024
Q1
$39.1M Buy
656,913
+280,032
+74% +$15.2M 0.14% 105
2023
Q4
$19.9M Sell
376,881
-64,872
-15% -$3.17M 0.09% 168
2023
Q3
$20.9M Buy
441,753
+66,492
+18% +$3.3M 0.1% 171
2023
Q2
$17.6M Hold
375,261
0.08% 194
2023
Q1
$15M Buy
375,261
+196,021
+109% +$8.07M 0.08% 201
2022
Q4
$6.97M Buy
179,240
+17,188
+11% +$653K 0.04% 296
2022
Q3
$5.65M Buy
+162,052
New +$6.5M 0.03% 317
2020
Q4
Sell
-50,700
Closed -$1.88M 827
2020
Q3
$1.88M Sell
50,700
-327,222
-87% -$11.7M 0.01% 424
2020
Q2
$13.7M Sell
377,922
-167,381
-31% -$5.14M 0.1% 120
2020
Q1
$14.4M Buy
545,303
+50,803
+10% +$2.25M 0.12% 113
2019
Q4
$25.7M Sell
494,500
-22,300
-4% -$1.16M 0.17% 99
2019
Q3
$24.6M Buy
516,800
+259,800
+101% +$12.4M 0.17% 97
2019
Q2
$12.1M Buy
257,000
+139,700
+119% +$6.58M 0.09% 165
2019
Q1
$5.1M Buy
+117,300
New +$4.83M 0.04% 269
2018
Q1
Sell
-6,500
Closed -$282K 590
2017
Q4
$282K Sell
6,500
-7,800
-55% -$340K ﹤0.01% 526
2017
Q3
$579K Sell
14,300
-95,246
-87% -$3.68M ﹤0.01% 411
2017
Q2
$4.07M Sell
109,546
-69,200
-39% -$2.54M 0.02% 260
2017
Q1
$6.46M Sell
178,746
-59,744
-25% -$2.07M 0.04% 208
2016
Q4
$7.72M Sell
238,490
-52,299
-18% -$1.54M 0.04% 212
2016
Q3
$7.74M Sell
290,789
-97,172
-25% -$2.46M 0.04% 224
2016
Q2
$8.46M Buy
387,961
+196,461
+103% +$4.09M 0.03% 243
2016
Q1
$3.98M Buy
+191,500
New +$3.66M 0.01% 317

Other funds holding ESNT

Grantham, Mayo, Van Otterloo & Co (GMO)'s ESNT Position: Q1 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Essent Group (ESNT) in Q1 2025, closing a stake of 566,121 shares — an estimated $30.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ESNT in Q1 2016 and held it in 25 quarters. The position peaked at $39.1M in Q1 2024. 332 funds tracked by Wall St. Rank hold ESNT as of Q1 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Essent Group position as of Q1 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 566,121 Essent Group shares in Q1 2025, an estimated $30.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Essent Group in Q1 2016 and held it in 25 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Essent Group position peaked at $39.1M in Q1 2024.
  • 332 funds tracked by Wall St. Rank held Essent Group as of Q1 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2025, filed 14 May 2025.